Susan Chi, M.D.
Instructor, Department of Pediatrics, Harvard Medical School
Active Staff, Pediatric Oncology, Dana-Farber Cancer Institute
Contact Info
Susan Chi
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: SW331
Phone: 617-632-4386
Fax: 617-632-4897
susan_chi@dfci.harvard.edu
Administrative Assistant
Pediatric Oncology
Harvard Medical School
44 Binney Street
Boston, MA, 02115
Phone: 617-632-4386
Fax: 617-632-4897
rosanne_chite@dci.harvard.edu
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: SW331
Phone: 617-632-4386
Fax: 617-632-4897
susan_chi@dfci.harvard.edu
Assistant
Rosanne WhiteAdministrative Assistant
Pediatric Oncology
Harvard Medical School
44 Binney Street
Boston, MA, 02115
Phone: 617-632-4386
Fax: 617-632-4897
rosanne_chite@dci.harvard.edu
DF/HCC Program Affiliation
Neuro-OncologyResearch Abstract
Not Available.Publications
- Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, Chi SN, Goumnerova L, Proctor M, Tarbell NJ, Marcus KJ, Pomeroy SL.Moyamoya following cranial irradiation for primary brain tumors in children.Neurology 2007 Mar 20;68(12):932-8.
17372129 - Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Poussaint TY, Vajapeyam S, Ullrich N, Goumnerova LC, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran MW.Phase II study of thalidomide and radiation in children with newly diagnosed brain stem glioma
17031553 - Ullrich NJ, Marcus K, Pomeroy SL, Turner CD, Zimmerman M, Lehmann LE, Scott RM, Goumnerova L, Gillan E, Kieran MW, Chi SN.Transverse Myelitis After Therapy For Primitive Neuroectodermal Tumors.Pediatr Neurol 2006 Aug;35(2):122-125.
16876009 - Zimmerman MA, Goumnerova LC, Proctor M, Scott RM, Marcus K, Pomeroy SL, Turner CD, Chi SN, Chordas C, Kieran MW.Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor.J Neurooncol 2005 Mar;72(1):77-84.
15803379 - Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL, Finlay JL.Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.J C
15611503




